Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.

Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
16 Oct 2020
Historique:
entrez: 17 10 2020
pubmed: 18 10 2020
medline: 18 10 2020
Statut: epublish

Résumé

Author Francesca Pentimalli was incorrectly associated with Histopathological Unit, IRCCS-Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy. The author's actual affiliation is Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, I-80131 Napoli, Italy.

Identifiants

DOI: 10.1038/s41419-020-03016-5 PMID: 33067416 PMC: PMC7567790
pubmed: 33067416
doi: 10.1038/s41419-020-03016-5
pii: 10.1038/s41419-020-03016-5
pmc: PMC7567790
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

867

Commentaires et corrections

Type : ErratumFor

Auteurs

Caterina Costa (C)

Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, I-80131, Napoli, Italy.
ORCID: 0000-0003-0909-7366

Paola Indovina (P)

Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, 19122, USA.
Institute for High Performance Computing and Networking, National Research Council of Italy (ICAR-CNR), Naples, Italy.

Eliseo Mattioli (E)

Histopathological Unit, IRCCS-Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124, Bari, Italy.

Iris Maria Forte (IM)

Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, I-80131, Napoli, Italy.

Carmelina Antonella Iannuzzi (CA)

Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, I-80131, Napoli, Italy.

Luca Luzzi (L)

Thoracic Surgery Unit, Department of Medicine, Surgery and Neuro Sciences, Diagnostic Imaging, University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, Italy.

Cristiana Bellan (C)

Department of Medical Biotechnologies, University of Siena, Siena, 53100, Italy.

Simona De Summa (S)

Molecular Diagnostics and Pharmacogenetics Unit-IRCCS-Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124, Bari, Italy.
ORCID: 0000-0001-9607-3754

Enrico Bucci (E)

Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, 19122, USA.
ORCID: 0000-0002-3317-8003

Domenico Di Marzo (D)

Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, 19122, USA.

Marisa De Feo (M)

Department of Cardiothoracic Sciences, Università degli Studi della Campania 'L. Vanvitelli' c/o Monaldi Hospital, Via L. Bianchi, 80131, Napoli, Italy.

Luciano Mutti (L)

Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, 19122, USA.
ORCID: 0000-0002-1578-2637

Francesca Pentimalli (F)

Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, I-80131, Napoli, Italy. f.pentimalli@istitutotumori.na.it.
ORCID: 0000-0003-4740-6801

Antonio Giordano (A)

Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, 19122, USA.
Department of Medical Biotechnologies, University of Siena, Siena, 53100, Italy.
ORCID: 0000-0002-5959-016X

Classifications MeSH